NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Operational Transition from the First-Generation Heidelberg Spectralis Optical Coherence Tomography [OCT("OCT1")] to the Second-Generation Heidelberg Spectralis OCT("OCT2")The Heidelberg Spectralis "OCT2", which recently became commercially available, is going to be implemented at the Johnson Space Center Flight Medicine Clinic and on board the International Space Station. Due to the increased scan rate of the "OCT2", this upgrade will allow for significant reduction in valuable crew testing time and also allow for additional capabilities, like OCT Angiography and Multi-Color Fundus Imaging. Due to the custom scans used to monitor Space Flight-Associated Neuro-ocular Syndrome (SANS) in our crewmembers, an evaluation to assess the impacts of transitioning from "OCT1" to "OCT2" was performed. An engineering assessment (N=1) was performed to identify any potential impacts of maintaining an "OCT1" on board ISS while implementing an "OCT2" in the JSC Clinic. "OCT2" implementation will lag JSC FMC clinical implementation due to the flight certification/manifestation process. The clinical assessment was performed (n=12) to identify any impacts due to the replacement of the "OCT1" with the "OCT2" to the longitudinal OCT data across a crewmember's mission/lifetime. The qualitative results from the engineering and clinical evaluation will be reported, as well as the quantitative assessment of the clinical variables
Document ID
20170009598
Acquisition Source
Johnson Space Center
Document Type
Abstract
Authors
Mason, S.
(Meit, Inc. Houston, TX, United States)
Brunstetter, T.
(Department of the Navy Washington, DC, United States)
Young, M.
(NASA Johnson Space Center Houston, TX, United States)
Van Baalen, M.
(NASA Johnson Space Center Houston, TX, United States)
Tarver, W.
(NASA Johnson Space Center Houston, TX, United States)
Derrick, R.
(Wyle Labs., Inc. Houston, TX, United States)
Wells, J.
(Wyle Labs., Inc. Houston, TX, United States)
Dey, B.
(Wyle Labs., Inc. Houston, TX, United States)
Todd, K.
(Wyle Labs., Inc. Houston, TX, United States)
Smith, B.
(Wyle Labs., Inc. Houston, TX, United States)
Patel, N.
(Houston Univ. Houston, TX, United States)
Date Acquired
October 5, 2017
Publication Date
January 22, 2018
Subject Category
Optics
Aerospace Medicine
Report/Patent Number
JSC-CN-40591
Meeting Information
Meeting: Annual NASA Human Research Program Investigators'' Workshop (HRP IWS) 2018
Location: Galveston, TX
Country: United States
Start Date: January 22, 2018
End Date: January 25, 2018
Sponsors: NASA Headquarters
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available